2021
DOI: 10.2217/nnm-2021-0004
|View full text |Cite
|
Sign up to set email alerts
|

Insights From Nanotechnology in COVID-19: Prevention, Detection, Therapy and Immunomodulation

Abstract: The outbreak of SARS-CoV-2 infection has presented the world with an urgent demand for advanced diagnostics and therapeutics to prevent, treat and control the spread of infection. Nanotechnology seems to be highly relevant in this emergency due to the unique physicochemical properties of nanomaterials which offer versatile chemical functionalization to create advanced biomedical tools. Here, nano-intervention is discussed for designing effective strategies in developing advanced personal protective equipment k… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
36
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 41 publications
(36 citation statements)
references
References 90 publications
0
36
0
Order By: Relevance
“…Exact analyses need effective and sufficient isolation of RNA from samples to prevent infection or false-negative results. Table 4 provide a summary of the NPs used in the diagnostic detection of CoVs [ [185] , [186] , [187] , [188] , [189] , [190] ].…”
Section: Nanotechnology In Medicine; Nanomedicinementioning
confidence: 99%
“…Exact analyses need effective and sufficient isolation of RNA from samples to prevent infection or false-negative results. Table 4 provide a summary of the NPs used in the diagnostic detection of CoVs [ [185] , [186] , [187] , [188] , [189] , [190] ].…”
Section: Nanotechnology In Medicine; Nanomedicinementioning
confidence: 99%
“…173,174 NP-based vaccine development is now on the way in various pharmaceutical companies and research institutes. [175][176][177] Table 4 demonstrates some of the WHO-listed nanovaccines which are in clinical and preclinical phases. 177 Most NPs for use in nanovaccines are known to be biodegradable, biocompatible, and less toxic and, therefore, they can be safe and effective alternatives to the conventional vaccines.…”
Section: Nanovaccinationmentioning
confidence: 99%
“… 212 The main challenges encountered by conventional PPE are associated with their poor antitoxicity, difficulty in breathability, heat dissipation, and reusability. 176 Uncertainties are also rising on which, how, and how much they permit COVID-19 transmitability, especially in workplace settings and densely populated gathering areas which necessitates more trustworthy, cost-effective, efficient, and reusable PPE development. 213 Appropriate understanding of the role and the usage of PPE by the health staff and the public and ensuring an adequate supply system are considerable factors for imminent prevention of the pandemic.…”
Section: Nanostructure-based Covid-19 Managementmentioning
confidence: 99%
See 2 more Smart Citations